Proteome analysis of antiproliferative mechanism of 12-O- tetradecanoylphorbol 13-acetate on cultured nasopharyngeal carcinoma CNE2 cells

Journal of Proteome Research

Volumn 4, Issue 2, 2005, Pages 599-605

  Jiang, Peizhou ^a,b   Gan, Ming ^c   Huang, Hua ^a   Shen, Xinming ^a   Wang, Shuang ^a   Yao, Kaitai ^a  

^a Cancer Research Institute   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

12 O tetradecanoyl phorbol 13 acetate; Apoptosis; Nasopharyngeal carcinoma; Proteomics

Indexed keywords

ANTIMITOTIC AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEOME;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA; TECHNIQUE; TUMOR DIFFERENTIATION;

BASE SEQUENCE; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TETRADECANOYLPHORBOL ACETATE;

EID: 17444385654     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0497677     Document Type: Article

References (54)

1. Yuspa, S. H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res. 1994, 54, 1178-1189.
2. Zheng, X.; Chang, R. L.; Cui, X. X.; Avila, G. E.; Lee, S.; Lu, Y. P.; Lou, Y. R.; Shih, W. J.; Lin, Y.; Reuhl, K.; Newmark, H.; Rabson, A.; Conney, A. H. Inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) alone or in combination with all-trans retinoic acid on the growth of LNCaP prostate tumors in immunodeficient mice. Cancer Res. 2004, 64, 1811-1820.
3. Zheng, X.; Chang, R. L.; Cui, X. X.; Kelly, K. A.; Shih, W. J.; Lin, Y.; Strair, R.; Suh, J.; Man, Z. T.; Rabson, A.; Conney, A. H. Synergistic effects of clinically achievable concentrations of 12-O-tetrade-canoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells. Oncol. Res. 2000, 12 (9-10), 419-427.
4. Fedder, M.; Gonzalez, M. F. Nasopharyngeal carcinoma. Brief review. Am. J. Med. 1985, 79, 365-369.
5. Guy, G. R.; Gordon, J. Epstein Barr virus and a tumor promoting phorbol ester use similar mechanisms in the stimulation of human B-cell proliferation. Int. J. Cancer 1989, 43, 703-708.
6. Sun, N.; Chen, X. Y.; Wu, F.; Guo, Z. M.; Shen, S. J. The transfection and morphological changes of human embryonic nasopharyngeal epithelia infected by Epstein-Barr virus cooperated with promoter in vitro and in vivo. Chin. J. Exp. Clin. Virol. 1998, 12, 70-73.
7. Tomei, L. D.; Noyes, I.; Blocker, D.; Holliday, J.; Glaser, R. Phorbol ester and Epstein-Barr virus dependent transformation of normal primary human skin epithelial cells. Nature 1987, 329, 73-75.
8. Cirone, M.; Angeloni, A.; Barile, G.; Zompetta, C.; Venanzoni, M.; Torrisi, M. R.; Frati, L.; Faggioni, A. Epstein-Barr virus internalization and infectivity are blocked by selective protein kinase C inhibitors. Int. J. Cancer 1990, 45, 490-493.
9. Schlingemann, J.; Hess, J.; Wrobel, G.; Breitenbach, U.; Gebhardt, C.; Steinlein, P.; Kramer, H.; Furstenberger, G.; Hahn, M.; Angel, P.; Lichter, P. Profile of gene expression induced by the tumor promotor TPA in murine epithelial cells. Int. J. Cancer 2003, 104, 699-708.
10. Rahmsdorf, H. J.; Herrlich, P. Regulation of gene expression by tumor promoters. Pharmacol Ther. 1990, 48, 157-188.
11. Verhoeckx, K. C.; Bijlsma, S.; de Groene, E. M.; Witkamp, R. F.; van der Greef, J.; Rodenburg, R. J. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics 2004, 4, 1014-1128.
12. Juan, H. F.; Lin, J. Y.; Chang, W. H.; Wu, C. Y.; Pan, T. L.; Tseng, M. J.; Khoo, K. H.; Chen, S. T. Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods. Electrophoresis 2002, 23, 2490-2504.
13. Gu, S. Y.; Zhao, W. P.; Zeng, Y.; Tang, W. P.; Zhao, M. L.; Deng, H. H. An epithelial cell line established from poorly differentiated nasopharyngeal carcinoma. Chin. J. Cancer 1983, 2, 70-72.
14. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
15. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
16. Rozengurt, E. Early signals in the mitogenic response. Science 1986, 234, 161-166.
17. Yamauchi, Y.; Nagasawa, K.; Mayumi, T.; Horiuchi, T.; Niho, Y. Activation of protein kinase C induces differentiation in the human T-lymphoblastic cell line MOLT-3. Br. J. Cancer 1989, 60, 15-19.
18. Ito, Y.; Tokuda, H.; Ohigashi, H.; Koshimizu, K. Distribution and characterization of environmental promoter substances as assayed by synergistic Epstein-Barr virus-activating system. Princess Takamatsu Symp. 1983, 14, 125-137.
19. Zeng, Y.; Miao, X. C.; Jaio, B.; Li, H. Y.; Ni, H. Y.; Ito, Y. Epstein-Barr virus activation in Raji cells with ether extracts of soil from different areas in China. Cancer Lett. 1984, 23, 53-59.
20. Lin, C. T.; Kao, H. J.; Lin, J. L.; Chan, W. Y.; Wu, H. C.; Liang, S. T. Response of nasopharyngeal carcinoma cells to Epstein-Barr virus infection in vitro. Lab. Invest. 2000, 80, 1149-1160.
21. Gracy, R. W. Glucosephosphate and triosephosphate isomerases. In. Isoenzymes: Current Topics in Biological and Medical Research; Rattazzi, M. C., Scandalios, J. C., Whitt, G. S., Eds.; Liss AR, Inc.: New York, 1982; pp 169-205.
22. Tatsuta, T.; Naito, M.; Oh-hara, T.; Sugawara, I.; Tsuruo, T. Functional involvement of P-glycoprotein in blood-brain barrier. J. Biol. Chem. 1992, 267, 20383-20391.
23. Yamaji, R.; Fujita, K.; Nakanishi, I.; Nagao, K.; Naito, M.; Tsuruo, T.; Inui, H.; Nakano, Y. Hypoxie up-regulation of triosephosphate isomerase expression in mouse brain capillary endothelial cells. Arch. Biochem. Biophys. 2004, 423, 332-342.
24. Chen, Y.; Wu, Q.; Song, S. Y.; Su, W. J. Activation of INK by TPA promotes apoptosis via PKC pathway in gastric cancer cells. World J. Gastroenterol. 2002, 8, 1014-1018.
25. Prasad, G. L.; Valverius, E. M.; McDuffie, E.; Cooper, H. L. Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ. 1992, 3, 507-513.
26. Vercoutter-Edouart, A. S.; Lemoine, J.; Le Bourhis, X.; Louis, H.; Boilly, B.; Nurcombe, V.; Revillion, F.; Peyrat, J. P.; Hondermarck, H. Proteomic analysis reveals that 14-3-3 sigma is down-regulated in human breast cancer cells. Cancer Res. 2001, 61, 76-80.
27. Van Hemert, M. J., Steensma, H. Y.; van Heusden, G. P. 14-3-3 proteins: key regulators of cell division, signaling and apoptosis. Bioassays 2001, 23, 936-940.
28. Dellambra, E.; Patrone, M.; Sparatore, B.; Negri, A.; Ceciliani, F.; Bondanza, S.; Molina, F.; Cancedda, F. D.; De Luca, M. Stratifin, a keratinocyte specific 14-3-3 protein, harbors a pleckstrin homology (PH) domain and enhances protein kinase C activity. J. Cell Sci. 1995, 108, 3569-3579.
29. Bhatia, K.; Siraj, A. K.; Hussain, A.; Bu, R.; Gutierrez, M. I. The tumor suppressor gene 14-3-3 sigma is commonly methylated in normal and malignant lymphoid cells. Cancer Epidemiol. Biomarkers Prev. 2003, 12, 165-169.
30. Kelly, R. B. Cell biology. Tracking an elusive receptor. Nature 1990, 345, 480-481.
31. Liu, Z.; Brattain, M. G.; Appert, H. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. Biochem. Biophys. Res. Commun. 1997, 231, 283-289.
32. Yu, L. R.; Zeng, R.; Shao, X. X.; Wang, N.; Xu, Y. H.; Xia, Q. C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 2000, 21, 3058-3068.
33. 2+)-binding protein with multiple EF-hand motifs. J. Biochem. (Tokyo) 1997, 121, 145-149.
34. Chan, W. Y.; Liu, Q. R.; Borjigin, J.; Busch, H.; Rennert, O. M.; Tease, L. A.; Chan, P. K. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Cell 1989, 56, 379-390.
35. Dergunova, N. N.; Bulycheva, T. I.; Artemenko, E. G.; Shpakova, A. P.; Pegova, A. N.; Gemjian, E. G.; Dudnik, O. A.; Zatsepina, O. V.; Malashenko, O. S. A major nucleolar protein B23 as a marker of proliferation activity of human peripheral lymphocytes. Immunol. Lett. 2002, 83, 67-72.
36. Zeller, K. I.; Haggerty, T. J.; Barrett, J. F.; Guo, Q.; Wonsey, D. R.; Dang, C. V. Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J. Biol. Chem. 2001, 276, 48285-48291.
37. Colombo, E.; Marine, J. C.; Danovi, D.; Falini, B.; Pelicci, P. G. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat. Cell Biol. 2002, 4, 529-533.
38. Kondo, T.; Minamino, N.; Nagamura-Inoue, T.; Matsumoto, M.; Taniguchi, T.; Tanaka, N. Identification and characterization of nucleophosmin/B23/numatrin which binds the antioncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 1997, 15, 1275-1281.
39. Dhar, S. K.; Lynn, B. C.; Daosukho, C.; St Clair, D. K. Identification of nucleophosmin as an NF-kappaB co-activator for the induction of the human SOD2 gene. J. Biol. Chem. 2004, 279, 28209-28219.
40. Chang, J. H.; Olson, M. O. A single gene codes for two forms of rat nucleolar protein B23 mRNA. J. Biol. Chem. 1989, 264, 11732-11737.
41. Singh, B.; Patel, H. V.; Ridley, R. G.; Freeman, K. B.; Gupta, R. S. Mitochondrial import of the human chaperonin (HSP60) protein. Biochem. Biophys. Res. Commun. 1990, 169, 391-396.
42. Rasmussen, R. K.; Ji, H.; Eddes, J. S.; Moritz, R. L.; Reid, G. E.; Simpson, R. J.; Dorow, D. S. Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2. Electrophoresis 1997, 18, 588-598.
43. Ji, H.; Reid, G. E.; Moritz, R. L.; Eddes, J. S.; Burgess, A. W.; Simpson, R. J. A two-dimensional gel database of human colon carcinoma proteins. Electrophoresis 1997, 18, 605-613.
44. Corbett, J. M.; Wheeler, C. H.; Baker, C. S.; Yacoub, M. H.; Dunn, M. J. The human myocardial two-dimensional gel protein database: update. Electrophoresis 1994, 15, 1459-1465.
45. 2+/ calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18. Mol. Cell Biol. 1997, 17, 3459-3467.
46. Curmi, P. A.; Nogues, C.; Lachkar, S.; Carelle, N.; Gonthier, M. P.; Sobel, A.; Lidereau, R.; Bieche, I. Overexpressioin of stathmin in breast carcinomas points out to highly proliferative tumors. Br. J. Cancer 2000, 82, 142-150.
47. Antonucci, F.; Chilosi, M.; Parolini, C.; Hamdan, M.; Astner, H.; Righetti, P. G. Two-dimensional molecular profiling of mantle cell lymphoma. Electrophoresis 2003, 24, 2376-2385.
48. Jeha, S.; Luo, X. N.; Beran, M.; Kantarjian, H.; Atweh, G. F. Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemia cells. Cancer Res. 1996, 56, 1445-1450.
49. Cilley, R. E., Zgleszewski, S. E.; Chinoy, M. R. Fetal lung development: airway pressure enhances the expression of developmental genes. J. Pediatr. Surg. 2000, 35, 113-118.
50. Alli, E.; Bash-Babula, J.; Yang, J. M.; Hait, W. N. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res. 2002, 62, 6864-6869.
51. Mistry, S. J.; Atweh, G. F. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mt. Sinai J. Med. 2002, 69, 299-304.
52. Barrett, J. C. Mechanisms for species differences in receptor-mediated carcinogenesis. Mutat. Res. 1995, 333, 189-202.
53. Gescher, A. Antiproliferative properties of phorbol ester tumor promoters. Biochem. Pharmacol. 1985, 34, 2587-2592.
54. Kazanietz, M. G. Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters. Mol. Carcinog. 2000, 28, 5-11.